Subscribe: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies
http://img.marketwire.com/rss/mwPBES.rss
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announced  announces  cannabis  company  jul  july  marketwired jul  marketwired july  marketwired  media  medical  today announced  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies

Marketwired - Equipment and Supplies



Marketwired - Equipment and Supplies



Last Build Date: Wed, 26 Jul 2017 09:02:27 EDT

Copyright: Copyright: (C) Marketwired
 



NetworkNewsWire Announces Publication on Leading Innovators Working to Unlock a Treatment for Alzheimer's

Wed, 26 Jul 2017 08:30:00 EDT

NEW YORK, NY--(Marketwired - Jul 26, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring India Globalization Capital, Inc. (NYSE MKT: IGC), a client of NNW positioned as a first mover in developing a portfolio of products using cannabis-based "combination therapies" for the treatment of pain and other conditions.




Medigus Broadens Availability of MUSE(TM) Through Distribution Agreement With ADMEDICS AG in Switzerland and Liechtenstein

Wed, 26 Jul 2017 07:00:00 EDT

New agreement expands accessibility of MUSE(TM) in new markets




Florida Hospital Nicholson Center Partners with STAN Institute to Launch Comprehensive Robotic Surgery Training Curriculum

Tue, 25 Jul 2017 09:02:00 EDT

International surgical training centers develop innovative, robotic surgical course launching in summer 2017




Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2017

Tue, 25 Jul 2017 09:00:00 EDT

SALT LAKE CITY, UT--(Marketwired - Jul 25, 2017) - In the second calendar quarter (2Q) and first half (1H) of 2017, Utah Medical Products, Inc. (NASDAQ: UTMD) achieved results which suggest the Company may significantly exceed previously announced goals for 2017.




Medovex Corporation DenerveX System First Cases to Commence in Germany

Tue, 25 Jul 2017 08:00:00 EDT

Dr. Martin Deeg to Use Recently CE Marked Device in Three Patients on July 26th in Stuttgart and Dr. Jan Spiller to Perform Three Additional Procedures in Bremen-Stenum on July 31st




AntriaBio Announces First Patient Dosed in Phase 1 Clinical Study of AB101

Tue, 25 Jul 2017 08:00:00 EDT

LOUISVILLE, CO--(Marketwired - July 25, 2017) - AntriaBio, Inc. ("AntriaBio or the "Company") (OTCQB: ANTB), a biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with diabetes and metabolic diseases, announced today the dosing of the first patient in a Phase 1 first-in-human clinical trial of its lead product candidate, AB101.




Livewire Ergogenics, Inc. Announces Strategic Development Agreements and Appointments to Advisory Board

Tue, 25 Jul 2017 08:00:00 EDT

ANAHEIM, CA--(Marketwired - Jul 25, 2017) - LiveWire Ergogenics, Inc. (OTC PINK: LVVV), a company focused on research partnerships, product development and commercialization of cannabinoid-based products, today announced it has entered into development agreements with seasoned horticulturists Kyle McKay and Jason Olson. The company also announced their appointments to the newly formed "7xPure" Advisory and Compliance Board.




Endexx to Showcase Phyto-Bites at the 4th Annual SuperZoo Show 2017 in Las Vegas

Tue, 25 Jul 2017 08:00:00 EDT

CAVE CREEK, AZ--(Marketwired - Jul 25, 2017) - Endexx Corporation (OTC PINK: EDXC), a provider of innovative phyto-nutrient-based food and nutritional products, announced today it will be attending the SuperZoo Show held on July 25-27, 2017 at the Mandalay Bay Convention Center in Las Vegas.




Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5(TM) Topical Gel

Tue, 25 Jul 2017 07:55:00 EDT

Company achieves milestone of its first U.S. regulatory filing for a medical device




Moleculin's New Drug for the Treatment of Glioblastoma Nears Clinical Trials at MD Anderson Cancer Center

Tue, 25 Jul 2017 07:30:00 EDT

HOUSTON, TX--(Marketwired - July 25, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced it has agreed to provide support to help accelerate the start of a physician-sponsored Investigational New Drug (IND) application to study the Company's drug candidate WP1066 for the treatment of adult glioblastoma (brain tumors).




MCIG Inc. Aggressively Seeks Acquisition of Medical and Recreational Marijuana License

Tue, 25 Jul 2017 07:00:00 EDT

HENDERSON, NV--(Marketwired - Jul 25, 2017) - mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis markets with innovative products, technologies, and services. mCig, Inc. is in a process of implementing a strategic plan that will help the company to accelerate its growth by expanding its reach in the cannabis market.




REMSleep Holdings Inc. Announces the DeltaWave and its Patent Application -- A New Revolutionary CPAP Nasal Interface Device Designed to Improve Treatment for Sleep Apnea Patients

Mon, 24 Jul 2017 12:21:24 EDT

DES MOINES, IA--(Marketwired - Jul 24, 2017) - REMSleep Holdings, Inc. (OTC PINK: RMSL) (OTC PINK: RMSLD) www.remsleeptech.com is pleased to announce that it has filed a non-provisional patent with the US Patent and Trademark Office (Patent number 15/595,990 filed on March 16, 2017). The patent is titled "New Generation Sleep Apnea Device" and will ultimately be marketed under the product name "DeltaWave."




Dewmar International BMC, Inc. (DEWM) Files Paperwork with the United States Patent and Trademark Office to Secure Intellectual Property Related to Cannabinoids and Parkinson's Disease

Mon, 24 Jul 2017 11:49:29 EDT

New provisional patent will advance Dewmar's intellectual property assets related to Cannabinoids and is a follow up to last week's USPTO filing for lung cancer




The Alliance for Regenerative Medicine Announces Second Reimbursement and Market Access-Focused White Paper in Three-Part Series Published in In Vivo

Mon, 24 Jul 2017 10:35:59 EDT

WASHINGTON, DC--(Marketwired - Jul 24, 2017) - The Alliance for Regenerative Medicine (ARM) today announced the publication of its reimbursement and market-access focused white paper, "New Payment and Financing Models for Curative Regenerative Medicines," available online today in In Vivo.




SpeeDx Eyes Clear Path toward Marketing Antibiotic Resistance and Detection Tests in US Market

Mon, 24 Jul 2017 09:35:25 EDT

On-track for De Novo submission after successful meeting with the FDA




GeoVax Joins with Scripps Research Institute and Institute of Human Virology at University of Maryland School of Medicine to Develop Lassa Fever Vaccine

Mon, 24 Jul 2017 09:00:00 EDT

ATLANTA, GA--(Marketwired - Jul 24, 2017) -  GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is collaborating with The Scripps Research Institute (TSRI) in La Jolla, CA, and the Institute of Human Virology (IHV) at the University of Maryland Medical School in Baltimore, MD, for advanced development of a preventive vaccine against Lassa hemorrhagic fever virus (LASV).




AXIM Biotech: Cannabinoid Potential Worth the Complexity -- SECFilings.com

Mon, 24 Jul 2017 09:00:00 EDT

REDONDO BEACH, CA--(Marketwired - Jul 24, 2017) -  SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering AXIM® Biotechnologies Inc. (OTCQB: AXIM) and its approach to developing cannabinoid-based therapeutics. Medical marijuana legalization may be sweeping the nation, but the term is a bit of a misnomer when it comes to actual medical evidence. After all, medical cannabis hasn't been registered as a medicine in any country and only a handful of cannabinoid medicines have reached the market. The upshot is that many companies are working on developing cannabinoid-based therapeutics that appear very promising in early clinical trials.




Cancer Immunotherapy Company Vaxil Appoints Dr. Terry Plasse as Chief Medical Officer

Mon, 24 Jul 2017 08:30:00 EDT

TORONTO, ON and REHOVOT, ISRAEL--(Marketwired - July 24, 2017) - VAXIL BIO LTD. (TSX VENTURE: VXL), an Israeli-Canadian biotech developing innovative immunotherapy treatments for cancer, is pleased to announce the appointment of Dr. Terry Plasse as its Chief Medical Officer, responsible for the Company's clinical program surrounding its drug candidate, ImMucinT. Dr. Plasse brings 30 years of clinical development experience, including advancing products from IND through to commercially marketed treatments for several big-pharma companies.




BriaCell Expands Targeted Pipeline via Acquisition of Sapientia Pharmaceuticals

Mon, 24 Jul 2017 08:30:00 EDT

BERKELEY, CA and VANCOUVER, BC--(Marketwired - July 24, 2017) - BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX VENTURE: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company with a proprietary vaccine technology, is pleased to announce that it has entered into a definitive share exchange agreement (the "Share Exchange Agreement") with its wholly-owned subsidiary, BriaCell Therapeutics Corp. ("BriaCell USA"), a Delaware corporation, Sapientia Pharmaceuticals, Inc. ("Sapientia") and all the shareholders of Sapientia (the "Sapientia Shareholders"). Sapientia, a biotechnology company based in Havertown, PA, that is developing novel targeted therapeutics for multiple indications including several cancers and fibrotic diseases.




Rennova Health Announces the Opening of Big South Fork Medical Center Is on Track for August 8 Following CMS Regional Office Licensure Approval

Mon, 24 Jul 2017 08:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - July 24, 2017) - Rennova Health, Inc. (NASDAQ: RNVA), (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces the Life Safety and Licensure Survey conducted by the Tennessee Department of Health East Regional Office has concluded its inspection of Rennova's subsidiary Big South Fork Medical Center (legal name: Scott Community Hospital, Inc.), thereby approving the opening of Big South Fork Medical Center as planned for August 8, 2017.




ORYZON presents final data on the Phase I trial with ORY-2001 at the Alzheimer's Association International Conference (AAIC-2017)

Mon, 24 Jul 2017 08:00:00 EDT

BARCELONA, SPAIN and CAMBRIDGE, MA--(Marketwired - July 24, 2017) -

  • Excellent safety data profile on 106 healthy volunteers
  • The molecule is brain penetrant
  • Data allows establishment of a safe administration scheme for long term efficacy studies



FDA Accepts Spectral's PMA for Toraymyxin(TM) for Review

Mon, 24 Jul 2017 08:00:00 EDT

TORONTO, ONTARIO--(Marketwired - July 24, 2017) - Spectral Medical Inc. (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock, today announced that the United States Food and Drug Administration ( "FDA") has accepted its rolling PMA application for ToraymyxinT ("PMX") for review.




ProBility Media Corp. Further Expands International Educational and Training Product Offerings with Purchase of Cranbury International

Mon, 24 Jul 2017 07:57:46 EDT

HOUSTON, TX--(Marketwired - Jul 24, 2017) -  ProBility Media Corp. (OTCQB: PBYA), an EdTech company building the first full-service training and career advancement brand for the skilled trades, today announced that it has signed a binding letter of intent to purchase Cranbury International, an exporter of educational and reference materials, located in Montpelier, Vermont. The acquisition significantly expands ProBility's educational and training product offerings in South and Central America and the Caribbean. The closing is expected within 30 days.




Genetic Technologies Receives Nasdaq Deficiency Notice

Fri, 21 Jul 2017 21:57:53 EDT

MELBOURNE, AUSTRALIA--(Marketwired - Jul 21, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), today announced that on 20 July 2017, it received a notification letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market, notifying the Company that its closing bid price has been below the minimum $US1.00 per share requirement for a period of 30 consecutive business days and that the Company has not met the minimum bid price requirement of $US1.00 per share for continued inclusion under Nasdaq Marketplace Listing Rules (the "Rules").




eWellness Signs LOI For Comprehensive PT Services with US Health Center and another US Healthcare Payer Group

Fri, 21 Jul 2017 09:00:00 EDT

CULVER CITY, CA--(Marketwired - Jul 21, 2017) - eWellness Healthcare Corporation -- (OTCQB: EWLL) -- a provider of the state of the art PHZIO Platform for the physical therapy and telehealth markets, announced today that it has signed a Letter of Intent Agreement between US Health Center, Inc. ("USHC") and an undisclosed US healthcare provider. Between both USHC and the undisclosed US healthcare payer group they anticipate having approximately 100,000 healthcare insured customers by the end of 2017. The Parties to this LOI have agreed to use their best efforts to conclude Definitive Agreements between the Parties over the next 90 days. According to eWellness, these new agreements (if executed) are anticipated to generate initially up to $4.2 million in annual reoccurring gross revenue for the Company. This level of sales is anticipated to allow the Company to gain cash flow positive operations during the latter part of 2017.




ECPO Files Issuers Company Related Action Notification with the Financial Industry Regulatory Authority requesting Name and Symbol Change

Thu, 20 Jul 2017 13:19:52 EDT

The Company Also Updated Progress on the Validation Process for its ITV-1 Patented HIV/AIDS Treatment




NSAV to Spin-Off Hemp Beer Subsidiary to Shareholders

Thu, 20 Jul 2017 09:20:00 EDT

CRESCO, PA--(Marketwired - Jul 20, 2017) -  NSAV Holding, Inc. (OTC: NSAV), announced today that the Company will spin-off its hemp beer division as a stand-alone public company. In conjunction with the spin-off, NSAV shareholders will be awarded shares in the proposed public entity based upon their holdings in NSAV. The Company has already formed Hemp Beer Inc., a Colorado corporation, and has begun construction of its hemp beer website, http://www.hempbeer.net.




SANUWAVE Appoints Alat Medika Indonesia as Distributor for dermaPACE and Liaison to Clinical Trials Participation for Company's Wound Care Product(s) in Indonesia

Thu, 20 Jul 2017 09:00:00 EDT

SUWANEE, GA--(Marketwired - Jul 20, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the Company has appointed Alat Medika Indonesia as distributor for dermaPACE® and liaison for clinical trials participation for Company's wound care product in Indonesia. The expected revenue from this agreement will be north of $1 million over the next three years.




Medical Marijuana Reports Record Month of Sales -- CFN Media

Thu, 20 Jul 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Jul 20, 2017) -  CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article on Medical Marijuana Inc.'s (OTC PINK: MJNA) Kannaway® subsidiary and its record monthly sales in June.




Heating Up: Who Benefits from the Growth in Vaping? -- CFN Media

Thu, 20 Jul 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Jul 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining the growth of vaping as an alternative to smoking, and Nutritional High International Inc.'s (CSE: EAT) (OTC: SPLIF) FLI liquid concentrate product line. Smoking tobacco has been popular for thousands of years, but vaporizers are quickly replacing the habit with a healthier alternative -- especially in the cannabis industry. These vaporizers provide a cheaper and healthier alternative to smoking, while providing a smoother and more socially-acceptable experience.




Propanc Biopharma Receives Acceptance of Key Patent Application for Cancer Treatment in China

Thu, 20 Jul 2017 08:30:00 EDT

Patent covers use of a pharmaceutical composition comprising trypsinogen and chymotrypsinogen




ANGLE plc: Preclinical Study Presented At Tumor Boston Summit

Thu, 20 Jul 2017 08:15:24 EDT

GUILDFORD, UNITED KINGDOM--(Marketwired - Jul 20, 2017) - ANGLE plc (AIM: AGL) (OTCQX: ANPCY)




Amfil Technologies Inc. Announces Purchase Order Commitment for EcoPr03 GRO3 Systems & Roto-Gro Units

Thu, 20 Jul 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - Jul 20, 2017) - Amfil Technologies Inc. (OTC PINK: AMFE) is pleased to announce that its sales team has received a purchase order commitment to outfit a portion of an up and coming Canadian cannabis cultivator with 5 EcoPrO3 GRO3 Antimicrobial Systems as well as 100 Roto-Gro Hydroponic Systems.




ORYZON to Regain Rights to ORY-1001 (RG6016)

Thu, 20 Jul 2017 07:16:55 EDT

Management to Host two Web Conferences today, July 20th

- at 10:00 am CET in Spanish and

- at 8:30 am ET in English




The Alliance for Regenerative Medicine Announces Presenting Companies at 2017 Cell & Gene Meeting on the Mesa

Wed, 19 Jul 2017 10:16:21 EDT

WASHINGTON, DC--(Marketwired - Jul 19, 2017) - The Alliance for Regenerative Medicine (ARM) today announced the initial slate of companies selected to present at its upcoming Cell & Gene Meeting on the Mesa annual conference, October 4-6, 2017.







UPDATE - Medovex Corporation Announces First Human Cases Using Its DenerveX Device and First Revenue Events

Wed, 19 Jul 2017 09:17:59 EDT

Highly Disruptive and Patented Less Invasive Device with Faster Recovery Time than Current Surgical Treatment Options for Facet Joint Syndrome




Mobile Games Provide Inroads to Cannabis Consumers -- CFN Media

Wed, 19 Jul 2017 09:13:30 EDT

SEATTLE, WA--(Marketwired - Jul 19, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article taking a closer look at fully-reporting First Harvest Corp. (OTCQB: HVST) and how mobile games could help cannabis companies reach consumers in an otherwise off-limits advertising environment.